Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)-Reference-Cited by-同舟云学术

Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)

Published:2015-05-12 Issue:4 Volume:35 Page:390-400
ISSN:0919-6544
Container-title:Neuropathology
language:en
Short-container-title:Neuropathology

Author:

Cairns Nigel J.¹²³,Perrin Richard J.¹³,Franklin Erin E.¹²,Carter Deborah¹³,Vincent Benjamin¹³,Xie Mingqiang¹²,Bateman Randall J.¹²,Benzinger Tammie¹⁴,Friedrichsen Karl⁴,Brooks William S.⁵⁶,Halliday Glenda M.⁵⁶,McLean Catriona⁷,Ghetti Bernardino⁸,Morris John C.¹²³, ,

Affiliation:

1. Knight Alzheimer's Disease Research Center; Washington University School of Medicine; St. Louis Missouri USA

2. Department of Neurology; Washington University School of Medicine; St. Louis Missouri USA

3. Division of Neuropathology; Department of Pathology & Immunology; Washington University School of Medicine; St. Louis Missouri USA

4. Department of Radiology; Washington University School of Medicine; St. Louis Missouri USA

5. Neuroscience Research Australia; Sydney New South Wales Australia

6. Department of Medicine; University of New South Wales; Sydney New South Wales Australia

7. Florey Institute of Neuroscience and Mental Health; University of Melbourne; Victoria Australia

8. Department of Pathology and Laboratory Medicine; Indiana University School of Medicine; Indianapolis Indiana USA

Funder

National Institutes of Health

ALzheimer's Association

AstraZeneca AB

Bristol-Myers Squibb

Eisai Global Clinical Development

Elan Corporation plc

Eli Lilly and Company

Forest Laboratories

GlaxoSmithKline

Institute for the Study of Aging

Merck and Co. Inc.

National Institute of Biomedical Imaging and Bioengineering

Novartis Pharmaceuticals Corporation

Pfizer Inc.

Wyeth Research

Publisher

Wiley

Subject

Clinical Neurology,General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/neup.12205/fullpdf

Reference26 articles.

1. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception;Weiner;Alzheimers Dement,2012

2. The Alzheimer's disease neuroimaging initiative: progress report and future plans;Weiner;Alzheimers Dement,2010

3. Developing an international network for Alzheimer research: the Dominantly Inherited Alzheimer Network;Morris;Clin Investig (Lond),2012

4. Clinical and biomarker changes in dominantly inherited Alzheimer's disease;Bateman;N Engl J Med,2012

5. Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium;Alafuzoff;Acta Neuropathol,2008

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives;Alzheimer's & Dementia;2024-06-21

2. A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function;Alzheimer's & Dementia;2024-05-21

3. Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease;PLOS Biology;2024-04-30

4. Multiple checkpoints ensure ribosomes have the correct end;PLOS Biology;2024-04-30

5. α‐Synuclein seed amplification assay detects Lewy body co‐pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden;Alzheimer's & Dementia;2024-04-26